EUCTR2007-003867-36-IT
Active, not recruiting
Not Applicable
PILOT STUDY OF PHARMACOGENETICS, CLINICAL EFFICACY AND TOLERABILITY OF CLOZAPINE IN PATIENTS AFFECTED BY SCHIZOPHRENIA, SCHIZOAFFECTIVE DISORDERS AND BIPOLAR DISORDERS WITH PSYCHOTIC FEATURES - ND
AZIENDA OSPEDALIERA PISANA0 sitesOctober 9, 2007
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- SCHIZOPHRENIA, SCHIZOAFFECTIVE DISORDERS AND BIPOLAR DISORDERS WITH PSYCHOTIC FEATURES
- Sponsor
- AZIENDA OSPEDALIERA PISANA
- Status
- Active, not recruiting
- Last Updated
- 14 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age greater than 18 years and lower than 65 years. Diagnosis of schizophrenia, schizoaffective disorders and bipolar disorders with psychotic features (DSM\-IV criteria). Treatment with clozapine since at least 14 days. Patients? agreement to follow up with measurement of clozapine and norclozapine plasma levels. Signature of written informed consent.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range
- •F.1\.3 Elderly (\>\=65 years) no
- •F.1\.3\.1 Number of subjects for this age range
Exclusion Criteria
- •Age lower than 18 years or higher than 65 years. Epatic or renal failure. Cardiopathies. Parkinson?s disease; Epilepsy and predisposing conditions. Depressive disorders. Myasthenia gravis. Paralytic ileus. Prostate hyperplasia. Familial or personal case history of glaucoma. Respiratory diseases. Familial or personal case history of jaundice or hematological diseases. Familial or personal case history of photosensitization. Personal case history of substance abuse in the last year. Pregnancy or breast\-feeding.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Clinical study to find out how well wilate works in little children with severe von Willebrand diseaseEUCTR2020-004344-28-DEOctapharma Pharmazeutika Produktionsges.m.b.H.12
Active, not recruiting
Phase 1
Clinical study to find out how well wilate works in little children with severe von Willebrand diseaseRoutine prophylaxis in children under the age of 6 years with severe VWDMedDRA version: 20.0Level: LLTClassification code 10055168Term: Von Willebrand's factor deficiencySystem Organ Class: 100000004850Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]EUCTR2020-004344-28-CZOctapharma Pharmazeutika Produktionsges.m.b.H.12
Active, not recruiting
Not Applicable
Study to evaluate the efficacy, metabolism and safety of human immune globulin in patients with primary immunodeficiency diseases.EUCTR2009-011434-10-Outside-EU/EEAOCTAPHARMA AG51
Active, not recruiting
Not Applicable
CLINICAL STUDY TO EVALUATE THE EFFICACY, PHARMACOKINETICS AND SAFETY OF IMMUNOGLOBULIN INTRAVENOUS (HUMAN) 10% (NEWGAM) IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASESEUCTR2009-011434-10-DEOCTAPHARMA AG50
Active, not recruiting
Phase 1
A fibrinogen concentrate study in paediatric patients with inherited fibrinogen deficiencyAfibrinogenaemia or severe hypofibrinogenaemiaMedDRA version: 16.1Level: LLTClassification code 10052651Term: AfibrinogenaemiaSystem Organ Class: 100000004850MedDRA version: 16.1Level: PTClassification code 10051125Term: HypofibrinogenaemiaSystem Organ Class: 10005329 - Blood and lymphatic system disordersTherapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]EUCTR2013-000261-36-FRFB Biotechnologies16